A brain with dementia is visibly smaller than a healthy brain. The folds on the surface appear thinner and more widely spaced, the fluid-filled chambers in the center are noticeably enlarged, and in advanced cases, the overall mass can be dramatically reduced. These changes are visible to the naked eye at autopsy and detectable years earlier on brain scans. The specific pattern of shrinkage varies by dementia type, but all forms share one core feature: the progressive loss of brain tissue and the connections between neurons.
The Visible Shrinkage
The most striking feature of a dementia brain is its size. A healthy brain fits snugly inside the skull, with its folds (called gyri) pressed closely together and its grooves (called sulci) relatively narrow. In dementia, those grooves widen by up to 40%, and the folds flatten and thin out. The brain pulls away from the skull, leaving visible gaps filled with cerebrospinal fluid. One of the most prominent changes is the widening of a deep groove along the side of the brain called the sylvian fissure, which becomes noticeably larger in Alzheimer’s disease compared to a healthy brain of the same age.
The fluid-filled chambers at the brain’s center, known as ventricles, balloon outward as surrounding tissue dies off. When brain tissue is lost, fluid rushes in to fill the space. On a brain scan, this ventricular enlargement is one of the most obvious markers. The overall folding complexity of the brain surface also decreases measurably: in young adults, the folding index averages around 2.48, drops to 2.42 in normal aging, and falls further to 2.32 in Alzheimer’s disease. That may sound like a small shift, but it reflects widespread loss of the intricate surface architecture the brain depends on for processing.
Where the Brain Shrinks First
Dementia doesn’t attack the whole brain evenly. In Alzheimer’s disease, the damage starts in a small, seahorse-shaped structure deep in the brain called the hippocampus, which is critical for forming new memories. By the time someone has an Alzheimer’s diagnosis, hippocampal volume is typically reduced by about 25% compared to a healthy person of the same age. The entorhinal cortex, a neighboring region that feeds information into the hippocampus, shrinks even more dramatically, losing 38% to 40% of its volume. These losses begin before symptoms appear and are already underway during mild cognitive impairment.
From there, the shrinkage spreads outward into the temporal and parietal lobes, affecting language, spatial awareness, and the ability to recognize familiar faces. In advanced Alzheimer’s, the frontal lobes also thin significantly, which is when personality changes and loss of judgment become more pronounced. The thalamus and caudate nucleus, structures deep in the brain that serve as relay stations connecting multiple brain networks, also lose volume.
What’s Happening at a Cellular Level
The visible shrinkage reflects catastrophic changes at the microscopic level. Two types of abnormal protein deposits are the hallmarks of Alzheimer’s disease, the most common form of dementia. The first is a sticky protein fragment called beta-amyloid, which clumps together between neurons to form dense plaques. These plaques disrupt cell-to-cell communication and trigger inflammation. The second is a protein called tau, which normally acts like scaffolding inside neurons, helping transport nutrients along the cell’s internal highway. In Alzheimer’s, tau detaches from this scaffolding and tangles together inside the neuron, choking off its transport system and eventually killing the cell.
These two processes appear to feed each other. Abnormal tau accumulates first in memory-related regions, while amyloid plaques spread more broadly across the brain’s outer surface. Once amyloid buildup reaches a tipping point, tau spreads rapidly into new regions, accelerating the destruction.
The loss of synapses, the tiny connection points between neurons, is one of the earliest and most consequential changes. In the hippocampus, synaptic density drops by roughly 20% to 25% in early Alzheimer’s as measured by brain scans, and autopsy studies show even steeper losses: a 44% reduction in one hippocampal layer and 55% in another among people with mild disease. This synaptic loss is closely tied to the depletion of acetylcholine, a chemical messenger essential for memory and learning. Neurons that produce acetylcholine, concentrated in a region at the base of the brain, degenerate severely in Alzheimer’s, and the degree of that degeneration correlates directly with the severity of cognitive decline.
How Different Types of Dementia Look Different
Not all dementia brains look alike. The pattern of damage serves as a fingerprint for each type.
Alzheimer’s disease produces the classic pattern described above: hippocampal and temporal lobe shrinkage spreading outward, with amyloid plaques and tau tangles throughout. On metabolic brain scans, the temporal and parietal regions show reduced activity, while the occipital lobes at the back of the brain are relatively spared until late in the disease. The posterior cingulate, a region involved in memory retrieval, is characteristically affected early.
Vascular dementia looks fundamentally different. Instead of the widespread cortical thinning seen in Alzheimer’s, the damage concentrates in the brain’s white matter, the deep wiring that connects different regions. Scans reveal bright patches of damaged white matter, small holes called lacunar infarcts in the deep brain structures, and sometimes evidence of prior strokes. About 57% of vascular dementia cases show damage concentrated in subcortical areas like the basal ganglia, thalamus, and deep white matter. Hippocampal shrinkage is milder, around 11% compared to Alzheimer’s 25%.
Frontotemporal dementia produces perhaps the most dramatic visual pattern. The frontal and anterior temporal lobes can shrink so severely that the atrophy appears extreme and sharply circumscribed, while the back of the brain remains strikingly preserved. The earliest changes occur in a network that includes the anterior cingulate, orbital frontal cortex, and a region called the insula. In the semantic variant, the front portions of the temporal lobes degenerate asymmetrically, with one side often far more affected than the other.
Lewy body dementia stands out on metabolic scans because, unlike Alzheimer’s, the occipital lobes at the back of the brain show reduced activity. The most sensitive finding is involvement of the lateral occipital cortex (detected in 88% of cases), while the posterior cingulate is relatively preserved, essentially the reverse of what Alzheimer’s looks like.
How Brain Scans Detect These Changes
Clinicians use several types of imaging to see these changes in living patients. Structural MRI provides the clearest picture of atrophy, revealing hippocampal shrinkage, widened sulci, enlarged ventricles, and cortical thinning. When radiologists visually inspect MRI scans for Alzheimer’s, they achieve about 83% sensitivity and 89% specificity, meaning the structural changes are reliable enough to support a diagnosis in most cases.
Metabolic PET scans, which measure how actively different brain regions consume glucose, perform even better, with sensitivity of 90% to 94%. In Alzheimer’s, the temporal and parietal regions light up dimmer than expected, reflecting reduced neural activity in those areas. Amyloid PET scans use specialized tracers that bind directly to amyloid plaques. In a healthy brain, the tracer concentrates mainly in white matter; in an Alzheimer’s brain, it accumulates in the gray matter, causing a visible loss of contrast between the two tissue types, particularly in the precuneus, posterior cingulate, and lateral frontal and temporal regions. If no amyloid accumulation shows up, Alzheimer’s disease is generally ruled out.
Beyond imaging, blood tests are now entering clinical use. In 2025, the first FDA-authorized blood tests for Alzheimer’s-related pathology became available, measuring specific protein ratios that indicate whether amyloid is accumulating in the brain. These tests won’t show you a picture of what the brain looks like, but they can detect the same underlying protein changes that drive the visible damage, years before significant atrophy appears on a scan.
How This Differs From Normal Aging
Healthy brains shrink with age too, which is part of what makes early dementia challenging to spot. Normal aging brings some ventricular enlargement, mild cortical thinning, and gradual white matter changes. The difference is one of degree and pattern. In normal aging, the brain loses volume slowly and relatively evenly. In Alzheimer’s, the hippocampus and entorhinal cortex shrink far faster and more severely than surrounding regions. The folding index drops more steeply. The ventricles expand more aggressively, with the greatest enlargement concentrated around the lateral ventricles.
Crucially, a normally aging brain does not accumulate the dense amyloid plaques and tau tangles that define Alzheimer’s disease. Some amyloid deposition can occur in older adults without dementia, but the combination of both amyloid and tau pathology, now considered the biological definition of Alzheimer’s under 2024 diagnostic criteria, distinguishes the disease from the normal wear of time.